Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

The latest moves by movers and shakers in the medical device and diagnostics industries

You may also be interested in...



People In Brief

Endo Health Systems names president of American Medical Systems subsidiary. MAKO Surgical Senior VP of Sales & Marketing resigns. More people briefs.

Endo Boosts Urology Device Presence With $2.9 Billion AMS Bid

Endo Pharmaceuticals has made its second big jump into the urology device space in less than a year, announcing April 11 that it will pay $2.9 billion in cash for American Medical Systems.

People In Brief

Endologix names former Bard exec to CEO post: Maker of Powerlink endoluminal stent grafts for abdominal aortic aneurysms names John McDermott president and CEO, effective May 12. McDermott formerly served as president of C.R. Bard's peripheral vascular division and brings 20 years of experience in the vascular device industry. He replaces Endologix' Paul McCormick, who will remain a director of the Irvine, Calif.-based company. The appointment follows "an extensive nationwide search," noted Endologix Chairman Franklin Brown. "We are confident that John has the ideal professional background to take our company to the next level.

Topics

UsernamePublicRestriction

Register

OM014142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel